中文 | English
Return
Total: 69 , 1/7
Show Home Prev Next End page: GO
Author:(Dok-Hyun YOON)

1.Serum beta-2 microglobulin in malignant lymphomas: an old but powerful prognostic factor.

Changhoon YOO ; Dok Hyun YOON ; Cheolwon SUH

Blood Research 2014;49(3):148-153

2.Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma

Heejung CHAE ; Dok Hyun YOON

Korean Journal of Medicine 2019;94(2):152-158

3.Chimeric Antigen Receptor T-Cell Therapy for Diffuse Large B-Cell Lymphoma

Heejung CHAE ; Dok Hyun YOON

Korean Journal of Medicine 2019;94(2):152-158

4.Screening Tests for Early Diagnosis of Multiple Myeloma and Related Plasma Cell Disorders

Jin Seok KIM ; Sung-Soo YOON ; Chang-Ki MIN ; Je-Jung LEE ; Dok Hyun YOON ; Kihyun KIM

Korean Journal of Medicine 2021;96(5):371-381

7.Prognostic value of immunohistochemical algorithms in gastrointestinal diffuse large B-cell lymphoma.

Hee Sang HWANG ; Dok Hyun YOON ; Cheolwon SUH ; Chan Sik PARK ; Jooryung HUH

Blood Research 2013;48(4):266-273

8.GLUT1 as a Prognostic Factor for Classical Hodgkin's Lymphoma: Correlation with PD-L1 and PD-L2 Expression.

Young Wha KOH ; Jae Ho HAN ; Seong Yong PARK ; Dok Hyun YOON ; Cheolwon SUH ; Jooryung HUH

Journal of Pathology and Translational Medicine 2017;51(2):152-158

9.Intestinal Diffuse Large B-Cell Lymphoma: An Evaluation of Different Staging Systems.

Hee Sang HWANG ; Dok Hyun YOON ; Cheolwon SUH ; Chan Sik PARK ; Jooryung HUH

Journal of Korean Medical Science 2014;29(1):53-60

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 69 , 1/7 Show Home Prev Next End page: GO